Delivery Order 75N93018D00011-75N93019F00311
Award Date 8/19/19
Potential Completion Date 4/18/25
Potential Value $2.7M
Federal Agency
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Germany
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
3
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to IDT Biologika GMBH, a foreign-owned, for-profit biotechnology company based in Germany. The contract is a $70,108.14 delivery order under a larger indefinite-delivery/indefinite-quantity (IDIQ) contract vehicle for manufacturing and characterization services for vaccines and other biologics for infectious diseases. The...
- This is a firm fixed-price delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to IDT Biologika GMBH, a German biotechnology company. The $1,366,000 contract is for the development, manufacturing, and characterization of various biological materials to support infectious disease research and pandemic preparedness efforts, including influenza virus human challenge material, Staphylococcus aureus...
- This is a fixed-price delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to IDT Biologika GMBH, a German biotechnology company. The contract is for the manufacturing of master cell banks to support COVID-19 pandemic preparedness efforts. The base award is for $20,462.00, with a total potential ceiling value of $554,341.00. The contract has an ultimate completion date of May 17, 2025,...
- This is a $24,295,876.00 delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to IDT Biologika GMBH, a German biotechnology company. The contract is for the manufacture of influenza virus human challenge material to support Phase 1 and 2 clinical trials. This work is likely part of NIAID's broader infectious disease research and pandemic preparedness efforts. The contract...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to IDT Biologika GMBH, a German biotechnology company. The $20,462.00 fixed-price delivery order contract is for process development of vaccine candidates, including for SARS-CoV-2. This contract is not associated with any set-aside designations. IDT Biologika GMBH has been awarded multiple prime federal contracts by NIAID for...
- This is a prime contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS), to IDT Biologika GMBH, a German biotechnology company. The $1,149,011.00 firm fixed price contract is for process development and master bank production of a Staphylococcus aureus protein A product. This work supports NIAID's infectious disease research and pandemic preparedness...
- This is a cost-plus-fixed-fee definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services. The contract, with a ceiling value of $86,670,401.90, is for biomedical (advanced) products and services. The prime contractor is Janssen Vaccines & Prevention B.V., a foreign-owned for-profit organization. The contract does not have a set-aside designation and has an ultimate completion date...
- This is a federal contract award made by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Integrated DNA Technologies, Inc. (IDT). The contract is a Blanket Purchase Agreement (BPA) valued at up to $100,000,000 with a period of performance through August 31, 2025. It allows for the delivery of various biological, oligonucleotide synthesis, and related laboratory supplies and services to support multiple federal...
- This federal contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Integrated DNA Technologies, Inc. (IDT), a leading provider of specialized nucleic acid products and services. The $20,000 firm-fixed-price contract is for the provision of custom oligonucleotide and RNA synthesis services to support NIAID's research and public health initiatives. This is a Blanket Purchase Agreement (BPA) call order under...
- This federal contract award, AMBIS #1748402, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Fraunhofer USA, Inc.'s Biotechnology Division Fraunhofer USA Center Mid-Atlantic, doing business as Fraunhofer Center For Molecular Biotechnology. The $364,793.00 firm fixed-price purchase order is for the development of influenza virus-like particles in a plant-based system. The contract does not have a set-aside designation and has an ultimate...